Clinical Trials Directory

Trials / Completed

CompletedNCT03970512

Apioc Toric/Spherical Single Vision Contact Lens

30 Day Fitting of a New Toric Contact Lens

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
51 (actual)
Sponsor
Lentechs, LLC · Industry
Sex
All
Age
18 Years – 35 Years
Healthy volunteers
Accepted

Summary

The Lentechs Apioc-S and Apioc-A contact lenses are made in an FDA-approved contact lens material indicated for single-vision and astigmatism. The novel lens design has a lenticular portion which is thicker than the optical portion of the lens. When applied to the eye, it is oriented in a superior position. Unlike contact lenses currently on the market, this innovative design improves lens stability by preventing lens rotation, and may improve tear flow behind the lens.

Conditions

Interventions

TypeNameDescription
DEVICEApioc-A and Apioc-S Contact LensesAppropriately fit, document and dispense a new spherical and toric contact lens design worn for up to 35 days.

Timeline

Start date
2019-05-31
Primary completion
2021-03-18
Completion
2021-03-18
First posted
2019-05-31
Last updated
2022-01-19

Locations

2 sites across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03970512. Inclusion in this directory is not an endorsement.

Apioc Toric/Spherical Single Vision Contact Lens (NCT03970512) · Clinical Trials Directory